July/August 2016

 

In this Issue

The Non Surgical Side of Retina

A look at some of the therapeutic and pharmacologic treatment approaches used outside of the OR.

  • Issue

  • Supplement

  • Insert

  • Insert

  • Insert

  • Insert

  • Insert

  • Insert

  • Supplement

  • Supplement

 
View the E-Dition

MEDICAL EDITORS’ PAGE

CATT 5-Year Data: Our Perspective

By Allen C. Ho, MD, and Robert L. Avery, MD

BUSINESS OF RETINA

PA Avenue Updates

Hacking the EpicCare Electronic Health Record System

How to make this widely used EHR system more efficient for high-volume vitreoretinal surgeons.

By William J. Foster, MD, PhD, and David Fleece, MD
Innovations in Retina

Visual Function Biomarkers Needed for Dry AMD

Early detection may allow treatment and possible reversal. Part 1 of a 2-part series.

By Aron Shapiro
Fellows’ Focus

Building and Maintaining a Referral Base

Tips for newly graduated fellows.

By Murtaza Adam, MD
Coding for Retina

A Potpourri of Complicated Surgical Coding Cases

These coding tips and examples can help minimize common problems related to claim denials.

By Riva Lee Asbell

RETINA SURGERY

Retina Pearls

Macular Hole Repair Using an ILM Patch

Concept of ILM flap or patch for use in challenging cases.

By Brian C. Joondeph, MD, MPS
Global Perspectives

Removal of Hydrogel Scleral Buckles

Surgery to remove these devices must involve caution due to risk of complications.

By Niels Crama, MD

MEDICAL RETINA

The Burden of Noninfectious Uveitis of the Posterior Segment: A Review

New pharmacologic treatment options are urgently needed.

By Steven Yeh, MD, and Jessica G. Shantha, MD

SPECIAL FOCUS: OCULAR ONCOLOGY

Which Tumor, What Imaging Modality?

Play your cards right and make the best bet for tumor diagnosis.

By Carol L. Shields, MD; Kareem Sioufi, MD; Timothy Fuller, MD; Timothy Higgins, BS; Sandor R. Ferenczy, CRA; and Jerry A. Shields, MD

Intraarterial Chemotherapy for Retinoblastoma

History, technique, and update on outcomes.

By Ryan S. Kim, BA; Mark J. Dannenbaum, MD; and Amy C. Schefler, MD

COVER FOCUS: THE NONSURGICAL SIDE OF RETINA

Profile of a Medical Retina Specialist

Shedding light on a new breed of clinicians.

By Jordana G. Fein, MD, MS, and Heeral R. Shah, MD

The Promise of Integrin Receptors for Treating Vitreoretinal Disorders

Study results suggest this class of drug has vitreolytic activity and a longer duration of effect than current treatments.

By Victor H. Gonzalez, MD

The Role of Laser in the Pharmacologic Era of Retina

Laser still plays a prominent part in managing retinal pathologies, and innovations in laser delivery suggest potential areas where indications might be expanded.

By Baruch Kuppermann, MD, PhD

WHAT’S NEW ON THE ANTI-PDGF FRONT?

An Oral Drug for Treatment of AMD?

The potential for this proposed treatment option could be significant for many patients and their caregivers.

By Carl C. Awh, MD

Improving Outcomes in Neovascular AMD With Combination Intravitreal Therapy

Could an anti-PDGF drug work with an anti-VEGF agent to provide better antiangiogenic effect than anti-VEGF monotherapy?

By Jeffrey S. Heier, MD

Combination Therapy for Neovascular AMD

Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell.

By Glenn J. Jaffe, MD

DEPARTMENTS

5Q With Ehsan Rahimy, MD

Ehsan Rahimy, MD, is a Surgical and Medical Vitreoretinal Specialist at the Palo Alto Medical Foundation in Palo Alto, Calif.

WEB EXCLUSIVE

Anti-TNFα Agents

By Eric Suhler, MD, MPH, and Thomas Albini, MD
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.